AP NEWS
Click to copy
Press release content from BusinessWire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from BusinessWire
Press release content from BusinessWire. The AP news staff was not involved in its creation.

Vivanza - Drug Insight (2018-2020) - ResearchAndMarkets.com

December 17, 2018

DUBLIN--(BUSINESS WIRE)--Dec 17, 2018--The “Vivanza - Drug Insight, 2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

Vivanza Drug Insight, 2018 highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location.

The report covers the Global Market Assessment of the Vivanza covering the historical global sales and also provides the Vivanza sales estimation during the forecasted period (2018-2020).

The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Vivanza and emerging therapies in this space.

Scope

A review of the Vivanza, based on information derived from company and industry-specific sources Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification Coverage of the Drug Master Files and API Manufacturers by country Patent Expiry Timeline and Exclusivity Details Route of Synthesis of the API Forecasted Sales Figure from 2018-2020 Market competition and emerging therapies SWOT Analysis

Key Topics Covered

1. Introduction

2. Vivanza - Overview

Product Description Route of Synthesis Mechanism of Action Pharmacology Pharmacodynamics Pharmacokinetics Adverse Reactions Regulatory Milestones by Region Deals and Partnerships

3. Product Details

4. Vivanza Sales Assessment

Historical Sales Forecasted Sales

5. Patent Details

6. Global API Manufacturers Assessment

Active Pharmaceutical Ingredient (API) Manufacturers by Country Active Pharmaceutical Ingredient (API) Manufacturers by Region

7. Market Competition

8. Emerging Therapies

8.1 Drug 1: Company 1

Product Description Research and Development Product Development Activities

9. SWOT Analysis

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/sf56x3/vivanza_drug?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181217005810/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Sexual and Reproductive Health Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/17/2018 04:07 PM/DISC: 12/17/2018 04:07 PM

http://www.businesswire.com/news/home/20181217005810/en

All contents © copyright 2019 The Associated Press. All rights reserved.